SHINE, a spinoff company that spent its formative years at Morgridge, is helping usher in the fusion energy age with several technologies, including a safe way to create life-saving medical isotopes.
Author: Morgridge Institute for Research
Skala to develop new imaging approach for retinal diseases
Morgridge investigator Melissa Skala has landed a grant from the National Eye Institute to develop a new imaging method that could allow for earlier disease detection, monitoring and treatment evaluation for retinal diseases.
Open wide: Detecting links between what’s in your mouth and illness
Using tiny specks of dental plaque, scientists at the Morgridge Institute for the first time compiled a sophisticated analysis that opens the door to using the trove of micro-organisms in your mouth as an indicator of other health issues.
By citations, UW–Madison faculty demonstrate strong impact
Morgridge biomedical imaging investigator Kevin Eliceiri is one of 17 UW–Madison researchers who made the 2021 Highly Cited Researchers List. Eliceiri has been cited more than 68,000 times in 228 publications and is recognized for his cross-disciplinary influence.
Scientists Pinpoint Structure of Antifungal, Challenge Binding Mechanism
Morgridge affiliate Chad Reinstra, a biochemist at UW–Madison, has unlocked the structure of Amphotericin B (AmB), a powerful and reliable drug that saves lives by obliterating serious fungal infections that can’t be diagnosed quickly.